ArticleHaematologica2022

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition.

Bing Z Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.